REDHILL BIOPHARMA LTD-SP ADR (RDHL:NASDAQ)

$0.65 0.0193 (3.0601%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 68

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed REDHILL BIOPHARMA LTD-SP ADR (RDHL:NASDAQ) News Sources

RedHill's Opaganib Enhances Efficacy of Neuroblastoma Chemo Combination and Augment Anti-Tumor Immunity in Triple-Negative Breast Cancer in Preclinical Studies - New Data Presented at AACR 2026

22-04-2026

yahoo.com

RedHill Biopharma Announces Full-Year 2025 Financial Results and Operational Highlights

27-04-2026

yahoo.com

RedHill's RHB-204 Demonstrates Comparable MAP Killing Efficacy to RHB-104 - Important Step in RHB-204 Development for MAP-related Crohn's Disease

30-04-2026

yahoo.com

RedHill Biopharma Advancing Opaganib Options for Novel Dual Host Directed and Direct Acting Antiviral Approach for Ebola Outbreak Biodefense Platforms

02-06-2026

yahoo.com

RedHill Launches Enforcement of $11 Million New York Supreme Court Final Judgment Against Kukbo

08-06-2026

yahoo.com

RedHill's Opaganib Receives FDA Rare Pediatric Disease Designation for Neuroblastoma in Addition to Current Orphan Drug Designation

09-06-2026

yahoo.com

RedHill Biopharma Announces Up To $19.4 Million Private Placement

18-06-2026

yahoo.com

RedHill Biopharma Announces Closing of Up To $19.4 Million Private Placement

22-06-2026

yahoo.com

Ebola Cases and Deaths Rapidly Mount - RedHill Updates on Opaganib Emergency Outbreak Development

28-07-2026

yahoo.com

Inflammatory Bowel Disease Market to Experience Strong Uptake During the Forecast Period (2026-2036), Driven by Development of Next-generation Therapies Targeting IL-23, TL1A, and S1P Pathways | DelveInsight

30-07-2026

yahoo.com

REDHILL BIOPHARMA LTD-SP ADR (RDHL:NASDAQ) Sentiment Trend

0 25 50 75 100 76 64 80 88 59 70 61 50 59 70 22-04-2026 27-04-2026 30-04-2026 02-06-2026 08-06-2026 09-06-2026 18-06-2026 22-06-2026 28-07-2026 30-07-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

REDHILL BIOPHARMA LTD-SP ADR (RDHL:NASDAQ) FAQs

toggle

What is the current price of REDHILL BIOPHARMA LTD-SP ADR (RDHL:NASDAQ)?

The current price of REDHILL BIOPHARMA LTD-SP ADR (RDHL:NASDAQ) is $0.65.


toggle

REDHILL BIOPHARMA LTD-SP ADR (RDHL:NASDAQ) absolute price change since previous trading day?

The absolute price change of REDHILL BIOPHARMA LTD-SP ADR (RDHL:NASDAQ) since the previous trading day is $0.0193.


toggle

REDHILL BIOPHARMA LTD-SP ADR (RDHL:NASDAQ) percentage price change since previous trading day?

The percentage price change of REDHILL BIOPHARMA LTD-SP ADR (RDHL:NASDAQ) since the previous trading day is 3.0601%.


toggle

What is the most recent average sentiment score for REDHILL BIOPHARMA LTD-SP ADR (RDHL:NASDAQ)?

The most recent average sentiment score for REDHILL BIOPHARMA LTD-SP ADR (RDHL:NASDAQ) is 68 out of 100.


toggle

What is the most recent average sentiment for REDHILL BIOPHARMA LTD-SP ADR (RDHL:NASDAQ)?

The most recent sentiment for REDHILL BIOPHARMA LTD-SP ADR (RDHL:NASDAQ) is .


SEC-8K** Filing Available For REDHILL BIOPHARMA LTD-SP ADR (RDHL:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.